Clinical Genetics · Boise, ID
NPI
1851785067
Since 2015
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
190 E Bannock St
Boise, ID, 83712
Phone (407) 376-9824
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,348
18 services
Medicare patients, 2023
12
Average age 58
Drug cost, 2024
$899K
34 prescriptions
Company payments, 2025
$30
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sheri Poskanzer prescribed most often to Medicare patients was Galafold (Migalastat Hcl), with 24 prescriptions and refills. In total Sheri Poskanzer wrote 34 Medicare prescriptions that cost $899K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Galafold Migalastat Hcl | 24 | 24 | Under 11 | $762K |
Brand drugs: 34 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheri Poskanzer $30 ($30 in general payments such as food, travel and fees) from 1 company. The largest payer was Ultragenyx Pharmaceutical Inc. with $30.
| Company | Payments | Amount |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE | 1 | $30 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.